Novonesis A/s Class B · OMXCOP:NSIS_B
Novonesis A/s Class B — Novonesis A S — Q2 2024 Earnings Presentation
14 slides from Novonesis A/s Class B's earnings presentation, Aug 28, 2024
Slide 1: Conference call H1 2024
Confe rence.calf H1 2024. 7 — Ser LT rms ce ‘ a Bat age he
Slide 2: Forward-looking statement
Forward-looking statement Disclaimer This announcement includes forward-looking statements. Such forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the control of the combined group and all of which are based on the combined group's current belief
Slide 3: H1 at 7% organic sales growth; Increased outlook
Sales and organic sales growth y/y 45% H1 at 7% organic sales growth; 55% Increased outlook Food & Health Biosolutions Planetary Health EURm Biosolutions • Organic sales growth (OSG) of 7% +7% • Growth driven by volume (~5%) and supported by pricing (~2%) OSG • Emerging markets 15%; developed market
Slide 4: Food & Health Biosolutions
Human Health Sales and organic sales growth, 26% Food & Health Biosolutions y/y Food & Health Biosolutions 74% EURm +6% Food & Beverages OSG Sales performance +9% OSG H1 2024 859.7 875.5 • Organic sales growth of 6%, driven by Food & Beverages, while 426.9 450.7 Human Health had a soft start to the
Slide 5: Food & Health Biosolutions: Food & Beverages
Sales and organic sales growth Food & Health Biosolutions: Food & Beverages y/y Food & Beverages EURm +8% OSG Sales performance +11% OSG H1 2024 634.4 650.9 • Organic sales growth of 8% across subareas and geographies 315.8 333.5 • Strong performance in Dairy and solid growth in Baking • Innovation
Slide 6: Food & Health Biosolutions: Human Health
Sales and organic sales growth Human Health y/y Food & Health Biosolutions: Human Health EURm +0% OSG Sales performance +5% OSG H1 2024 225.3 224.6 • Organic growth of 0% in line with expectations, due to a strong 111.1 117.2 comparable and order timing in HMO and Dietary supplements • Strong sales
Slide 7: Planetary Health Biosolutions
Household Care Sales and organic sales growth 35% Planetary Health Biosolutions y/y Planetary Health Biosolutions 65% EURm Agriculture, 8% Energy & Tech Sales performance OSG H1 2024 11% OSG • Organic sales growth of 8%, led by Household Care and 998.5 1,068.2 supported by Agriculture, Energy & Tech
Slide 8: Planetary Health Biosolutions: Household Care
Sales and organic sales growth Household Care y/y Planetary Health Biosolutions: Household Care EURm Sales performance 15% OSG H1 2024 16% OSG • Organic growth of 15%, with double-digit growth in all regions 330.0 377.7 from increased penetration, innovation, pricing and supported 161.1 185.8 by tim
Slide 9: Planetary Health Biosolutions: Agriculture, Energy & Tech
Sales and organic sales growth Agriculture, Energy & Tech y/y Planetary Health Biosolutions: Agriculture, Energy & Tech EURm 4% OSG Sales performance 9% H1 2024 668.5 690.5 OSG • Organic growth of 4%, driven by double-digit growth in Energy 313.7 341.7 and solid growth in Tech H1 2023 H1 2024 Q2 202
Slide 10: Financial results H1 2024
Financial results H1 2024 – Strong financials with underlying improvements across the lines – Merger-related divestment of lactase enzyme business completed with gain on sales in special items – Strong free cash flow generation with a positive one-off in operating cash flow H1 2024 H1 2023 Q2 2024 Q
Slide 11: Outlook 2024
Outlook 2024 • Organic sales growth of 7-8%, driven predominately by volume • Adjusted EBITDA margin of 35.5-36.5% • Gross margin expected to strengthen further over 2023 • Interim dividend approved at DKK 2.00 (EUR 0.27) per share Outlook 2024¹ Organic sales growth 7-8% Adjusted EBITDA margin 35.5-
Slide 12: Summary
Summary • Solid performance with strong momentum • Strong traction on integration activities • Prioritization continues to be key • Cost synergies at 80% run rate • Sales synergies confirmed to materialize from 2025 and onwards • Increased full-year outlook 12
Slide 13: Novonesis
hovonesis
Slide 14: Organic sales performance by region
Organic sales performance by region North America Developed markets H1 y/y: +2% H1 y/y: +3% Europe, the Middle East & Africa H1 y/y: +7% 65% 32% of sales of sales 36% of sales Asia Pacific Latin America H1 y/y: +14% Emerging markets H1 y/y: +12% H1 y/y: +15% 13% 19% 35% of sales of sales of sales 14